Clinical trial

Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertension

NCT01370096

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Vasopressin infusion Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Vasopressin infusion and epoprostenol inhalation Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertension

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2012-02-01

PhasePHASE2

Conditions

Pulmonary Hypertensionverified · MONDO: pulmonary hypertension

Interventions

Vasopressin infusionDRUG

Vasopressin infusion and epoprostenol inhalationDRUG

Sponsors & collaborators

University of Albertalead sponsor

Mapped research locations

EdmontonAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01370096 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.